Allison R. Larson, MD

Dr. Allison R. Larson

Assistant Professor of Dermatology

Boston University School of Medicine


To Schedule An Appointment: 617-638-7420

Shapiro Ambulatory Care Center

725 Albany Street, Suite 8B, Boston, MA 02118
Fax: 617-638-7289

Administrative Office:

Boston University School of Medicine, Dept of Dermatology

609 Albany Street, Boston, MA 02118
Tel: 617-358-9700
Fax: 617-358-9709


2003 BS, MSE Johns Hopkins University, Baltimore, MD
2008 MD Johns Hopkins University, Baltimore, MD
2012-2014 Residency Dermatology, Harvard University/Massachusetts General Hospital, Boston, MA
2014 Fellowship Dermatopathlogy, Harvard University, Boston MA

Clinical Specialty and/or Research Interest

  • General Dermatology
  • Gynecologic Dermatology
  • Medical Education
  • Research interest – Innovations in pre-clinical medical education


Dr. Larson sees general dermatology patients and holds a monthly gynecologic dermatology clinic at Boston Medical Center.  As an Assistant Dean for Academic Affairs at Boston University School of Medicine, her focus is on curriculum development.  Her research interests include innovative teaching methods for pre-clinical medical student education.

Selected Publications

1. Alani RM, Larson AR, Falanga V. Paving a new path towards academic medicine-A novel approach to graduate medical education in the United States. Acad Med. 2016;91(8):1039-40.

2. Larson AR, Yang CY. Anatomy laboratory as an opportunity to educate about skin lesions. Med Teach. 2016 38(6):637.

3. Granter SR, Laga AC, Larson AR. Calciphylaxis and the persistence of medical misinformation in the era of Google. Am J Clin Pathol. 2015 144(3):427-31. Larson AR, Granter SR.  Systemic lupus erythematosus-associated neutrophilic dermatosis – A review and update.  Adv Anat Pathol. 2014;21(4):248-53.

4. Larson AR, Yuijang GS, Dresser K, Zhan Q, Lezcano C, Woda BA, Yosufi B, Thompson JF, Scolyer RA, Mihm MC, Murphy GF, Lian CG.  Progressive loss of 5-hydroxymethylcytosine correlates with morphologic dysplasia in melanocytic lesions.  Mod Pathol. 2014 [Epub ahead of print].

5. Larson AR, Granter SR.  Systemic lupus erythematosus-associated neutrophilic dermatosis-an underrecognized neutrophilic dermatosis in patients with systemic lupus erythematosus.  Human Pathol. 2014;45(3):598-605.

6. Larson AR, Lee CW, Lezcano C, Fisher AH, Zhan Q, Huang J, Murphy GF.  Melanoma microsphere formation involves laminin-associated vasculogenic mimicry.  Am J Pathol. 2014;184(1):71-8.

7. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Zhan Q, Lian BQ, Lezcano C, Scolyer RA, Thompson JF, Houvras Y, Zon L, Mihm MC, Kaiser UB, Woda BA, Murphy GF, Shi YG.  5-Hydroxymethylcytosine is a unique epigenetic biomarker fundamental to melanoma progression.  Cell. 2012;150(6):1135-46.